PHARMACOKINETICS
Clinical trials for PHARMACOKINETICS explained in plain language.
Never miss a new study
Get alerted when new PHARMACOKINETICS trials appear
Sign up with your email to follow new studies for PHARMACOKINETICS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New pill shows promise in early trial for Hard-to-Treat cancers
Disease control Recruiting nowThis early-stage study tests an experimental oral drug, IPG7236, in adults with advanced solid tumors that have spread or cannot be removed. The main goals are to check safety, find the best dose, and see if the drug can shrink tumors. About 196 participants will take the pill tw…
Matched conditions: PHARMACOKINETICS
Phase: PHASE1, PHASE2 • Sponsor: Nanjing Immunophage Biotech Co., Ltd • Aim: Disease control
Last updated May 26, 2026 07:41 UTC
-
Scientists study High-Potency Weed's effects on pain and pleasure
Knowledge-focused Recruiting nowThis study looks at how smoking high-potency cannabis changes pain perception and feelings of a 'good drug effect' in people who use cannabis nearly every day. Researchers will also measure how long THC stays in the blood. The goal is to understand these effects both during norma…
Matched conditions: PHARMACOKINETICS
Phase: PHASE1 • Sponsor: University of California, Los Angeles • Aim: Knowledge-focused
Last updated May 26, 2026 07:38 UTC
-
Study aims to perfect antibiotic dosing for kids on ECMO
Knowledge-focused Recruiting nowThis study looks at how antibiotics behave in the bodies of critically ill newborns, infants, and children who are on a heart-lung machine called ECMO. The goal is to see if current antibiotic doses are effective and safe. Researchers will measure drug levels in the blood to find…
Matched conditions: PHARMACOKINETICS
Phase: NA • Sponsor: University Hospital, Ghent • Aim: Knowledge-focused
Last updated May 26, 2026 07:33 UTC
-
Healthy volunteers needed to test two forms of heart drug
Knowledge-focused Recruiting nowThis study tests two different forms of the cholesterol-lowering drug evolocumab in 400 healthy adults aged 18 to 60. The main goal is to see how the body absorbs and processes each version. Participants receive a single dose and are monitored for side effects and drug levels ove…
Matched conditions: PHARMACOKINETICS
Phase: PHASE1 • Sponsor: Amgen • Aim: Knowledge-focused
Last updated May 26, 2026 07:24 UTC
-
New inhaled drug RCS-21 put to the test in healthy volunteers
Knowledge-focused Recruiting nowThis early-stage study tests whether a single inhaled dose of RCS-21 is safe and tolerable in 24 healthy adults aged 18 to 64. Participants receive one dose and are closely monitored for side effects. The study does not aim to treat any disease, but to gather important safety and…
Matched conditions: PHARMACOKINETICS
Phase: PHASE1 • Sponsor: RNATICS GmbH • Aim: Knowledge-focused
Last updated May 26, 2026 07:21 UTC
-
Healthy volunteers test new way to deliver oxycodone
Knowledge-focused Recruiting nowThis early-stage study in 30 healthy adults measures how the body processes oxycodone when given as a new formulation called PF614, alone or with another drug called nafamostat. The goal is to understand drug levels and safety, not to treat any condition. Results will guide futur…
Matched conditions: PHARMACOKINETICS
Phase: PHASE1 • Sponsor: Ensysce Biosciences • Aim: Knowledge-focused
Last updated May 22, 2026 13:52 UTC
-
Are we giving kids the right antibiotic dose? new study investigates
Knowledge-focused Recruiting nowThis study looks at whether antibiotics given to critically ill children in the ICU reach the right levels in their blood to fight infections effectively. Researchers will measure drug concentrations after the first dose and at steady state in 640 children from newborns to age 15…
Matched conditions: PHARMACOKINETICS
Sponsor: University Hospital, Ghent • Aim: Knowledge-focused
Last updated May 18, 2026 12:13 UTC
-
New antibiotic combo tested in healthy volunteers – no cure yet
Knowledge-focused Recruiting nowThis early-stage study tests a new antibiotic combination (ceftibuten-ledaborbactam etzadroxil) in about 46 healthy adults aged 18-55. The goal is to check safety and how the drug moves through the body, not to treat any disease. Results will help decide if further studies are po…
Matched conditions: PHARMACOKINETICS
Phase: PHASE1 • Sponsor: Basilea Pharmaceutica • Aim: Knowledge-focused
Last updated May 14, 2026 12:05 UTC
-
New study tracks antifungal drug in critically ill kids
Knowledge-focused Recruiting nowThis study looks at how the antifungal medicine caspofungin behaves in children with severe infections, especially those with liver problems or on life support like ECMO. Researchers will measure drug levels in the blood to understand dosing better. The goal is to improve treatme…
Matched conditions: PHARMACOKINETICS
Sponsor: Children's Hospital of Fudan University • Aim: Knowledge-focused
Last updated May 04, 2026 16:19 UTC